Taltz is a prescription medicine available as a 80 mg/mL, 40 mg/0.5mL, 20 mg/0.25mL injection. For more information, call 1-800-545-5979 or go to taltz.lilly.com . This summary provides basic information about Taltz but does not include all information known about this medicine.

Instruct patients to inject the full amount and not to inject where the skin is tender, bruised, red, thick, or affected by psoriasis. For additional administration information, refer to the Instructions for Use included with the device. * Every 4 weeks. Starting dose of one 80 mg injection, followed by one 80 mg injection every 4 weeks thereafter.

2024年5月8日 · Taltz injection is used to treat plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis, which are all autoimmune disorders. Taltz works by reducing inflammation, which helps improve the symptoms of these conditions.

TALTZ® is indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. TALTZ is indicated for the treatment of...

Learn about Taltz (ixekizumab), a treatment for patients with moderate to severe plaque psoriasis (PsO), active psoriatic arthritis (PsA), active ankylosing spondylitis (AS), and active non-radiographic axial spondyloarthritis (nr-axSpA).

2024年5月8日 · Ixekizumab brand name is Taltz injection. Ixekizumab is a monoclonal antibody that works by binding and neutralizing a naturally occurring protein called interleukin 17A (IL-17A). This protein is involved in inflammation and how the immune system responds.

TALTZ is administered by subcutaneous injection every 4 weeks (Q4W). The recommended dosage in pediatric patients from 6 to less than 18 years of age with moderate-to-severe plaque psoriasis is based on the following weight

2024年11月13日 · TALTZ (ixekizumab) injection, for subcutaneous use - Initial ... 1.1 Plaque Psoriasis - TALTZ® is indicated for the treatment of patients 6 years of age and older with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or ...

2022年9月21日 · TALTZ is used to treat adults with active psoriatic arthritis and can be used alone or with another medicine called a conventional disease modifying anti-rheumatic drug (cDMARD), for example methotrexate.

TALTZ® is indicated for the treatment of patients 6 years of age and older with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. TALTZ is indicated for...